GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest: A post hoc analysis of the COMACARE trial
Jaana Humaloja, Marika Lähde, Nicholas J Ashton, Matti Reinikainen, Johanna Hästbacka, Pekka Jakkula, Hans Friberg, Tobias Cronberg, Ville Pettilä, Kaj Blennow, Henrik Zetterberg, Markus B Skrifvars, COMACARE Study Groups, Jaana Humaloja, Marika Lähde, Nicholas J Ashton, Matti Reinikainen, Johanna Hästbacka, Pekka Jakkula, Hans Friberg, Tobias Cronberg, Ville Pettilä, Kaj Blennow, Henrik Zetterberg, Markus B Skrifvars, COMACARE Study Groups
Abstract
Aim: To determine the ability of serum glial fibrillary acidic protein (GFAp) and tau protein to predict neurological outcome after out-of-hospital cardiac arrest (OHCA).
Methods: We measured plasma concentrations of GFAp and tau of patients included in the previously published COMACARE trial (NCT02698917) on intensive care unit admission and at 24, 48, and 72 h after OHCA, and compared them to neuron specific enolase (NSE). NSE concentrations were determined already during the original trial. We defined unfavourable outcome as a cerebral performance category (CPC) score of 3-5 six months after OHCA. We determined the prognostic accuracy of GFAp and tau using the receiver operating characteristic curve and area under the curve (AUROC).
Results: Overall, 39/112 (35%) patients had unfavourable outcomes. Over time, both markers were evidently higher in the unfavourable outcome group (p < 0.001). At 48 h, the median (interquartile range) GFAp concentration was 1514 (886-4995) in the unfavourable versus 238 (135-463) pg/ml in the favourable outcome group (p < 0.001). The corresponding tau concentrations were 99.6 (14.5-352) and 3.0 (2.2-4.8) pg/ml (p < 0.001). AUROCs at 48 and 72 h were 0.91 (95% confidence interval 0.85-0.97) and 0.91 (0.85-0.96) for GFAp and 0.93 (0.86-0.99) and 0.95 (0.89-1.00) for tau. Corresponding AUROCs for NSE were 0.86 (0.79-0.94) and 0.90 (0.82-0.97). The difference between the prognostic accuracies of GFAp or tau and NSE were not statistically significant.
Conclusions: At 48 and 72 h, serum both GFAp and tau demonstrated excellent accuracy in predicting outcomes after OHCA but were not superior to NSE.
Clinical trial registration: NCT02698917 (https://www.clinicaltrials.gov/ct2/show/NCT02698917).
Keywords: Biomarkers; Glial fibrillary acidic protein; Neurological outcome prognostication; Out-of-hospital cardiac arrest; Tau protein.
Conflict of interest statement
Declaration of Competing Interest J. Humaloja, M.L., N.J.A, M.R., J. Hästbacka, P.J., H.F., T.C. and V.P. have nothing to disclose. M.B.S. has received a lecture fee and a travel grant from BARD Medical (Ireland and South Korea, not related to this study). H.Z. has served at scientific advisory boards and/or as a consultant for AbbVie, Alector, Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies, CogRx and Red Abbey Labs; has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant at advisory boards or at data-monitoring committees for Abcam, Axon, Biogen JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Prothena, Roche Diagnostics and Siemens Healthineers and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, all unrelated to the work presented in this paper.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
Figures
References
- Björklund E., Lindberg E., Rundgren M., Cronberg T., Friberg H., Englund E. Ischaemic brain damage after cardiac arrest and induced hypothermia–a systematic description of selective eosinophilic neuronal death. A neuropathologic study of 23 patients. Resuscitation. 2014;85:527–532. doi: 10.1016/J.RESUSCITATION.2013.11.022.
- Lu-Emerson C., Khot S. Neurological sequelae of hypoxic-ischemic brain injury. NeuroRehabilitation. 2010;26:35–45. doi: 10.3233/NRE-2010-0534.
- Nolan J.P., Sandroni C., Böttiger B.W., et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care. Resuscitation. 2021;161:220–269. doi: 10.1016/J.RESUSCITATION.2021.02.012.
- Callaway C.W., Donnino M.W., Fink E.L., et al. Part 8: Post-Cardiac Arrest Care. Circulation. 2015;132:S465–S482. doi: 10.1161/CIR.0000000000000262.
- Wang C.H., Chang W.T., Su K.I., et al. Neuroprognostic accuracy of blood biomarkers for post-cardiac arrest patients: A systematic review and meta-analysis. Resuscitation. 2020;148:108–117. doi: 10.1016/j.resuscitation.2020.01.006.
- Metting Z., Wilczak N., Rodiger L.A., Schaaf J.M., van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology. 2012;78:1428–1433. doi: 10.1212/WNL.0b013e318253d5c7.
- Vos P.E., Jacobs B., Andriessen T.M.J.C., et al. GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology. 2010;75:1786–1793. doi: 10.1212/WNL.0b013e3181fd62d2.
- Larsson I.M., Wallin E., Kristofferzon M.L., Niessner M., Zetterberg H., Rubertsson S. Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome. Resuscitation. 2014;85:1654–1661. doi: 10.1016/j.resuscitation.2014.09.007.
- Kaneko T., Kasaoka S., Miyauchi T., et al. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation. 2009;80:790–794. doi: 10.1016/j.resuscitation.2009.04.003.
- Katsanos A.H., Makris K., Stefani D., et al. Plasma Glial Fibrillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage. Stroke. 2017;48:2586–2588. doi: 10.1161/STROKEAHA.117.018409.
- Vos P.E., van Gils M., Beems T., Zimmerman C., Verbeek M.M. Increased GFAP and S100β but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur J Neurol. 2006;13:632–638. doi: 10.1111/j.1468-1331.2006.01332.x.
- Vos P.E., Lamers K.J.B., Hendriks J.C.M., et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62:1303–1310. doi: 10.1212/01.WNL.0000120550.00643.DC.
- Hol E.M., Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121–130. doi: 10.1016/j.ceb.2015.02.004.
- Weingarten M.D., Lockwood A.H., Hwo S.Y., Kirschner M.W. A protein factor essential for microtubule assembly. PNAS. 1975;72:1858–1862. doi: 10.1073/pnas.72.5.1858.
- Williams D.R. Tauopathies: Classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Int Med J. 2006;36:652–660. doi: 10.1111/j.1445-5994.2006.01153.x.
- Wunderlich M.T., Lins H., Skalej M., Wallesch C.W., Goertler M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg. 2006;108:558–563. doi: 10.1016/j.clineuro.2005.12.006.
- Mörtberg E., Zetterberg H., Nordmark J., Blennow K., Rosengren L., Rubertsson S. S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment. Resuscitation. 2011;82:26–31. doi: 10.1016/j.resuscitation.2010.10.011.
- Randall J., Mörtberg E., Provuncher G.K., et al. Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study. Resuscitation. 2013;84:351–356. doi: 10.1016/j.resuscitation.2012.07.027.
- Blennow K., Hampel H., Weiner M., Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6:131–144. doi: 10.1038/nrneurol.2010.4.
- Öst M., Nylén K., Csajbok L., et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology. 2006;67:1600–1604. doi: 10.1212/01.WNL.0000242732.06714.0F.
- Mattsson N., Zetterberg H., Nielsen N., et al. Serum tau and neurological outcome in cardiac arrest. Ann Neurol. 2017;82:665–675. doi: 10.1002/ana.25067.
- Jakkula P., Reinikainen M., Hästbacka J., et al. Targeting two different levels of both arterial carbon dioxide and arterial oxygen after cardiac arrest and resuscitation: a randomised pilot trial. Intensive Care Med. 2018;44:2112–2121. doi: 10.1007/s00134-018-5453-9.
- Jakkula P., Reinikainen M., Hästbacka J., et al. Targeting low- or high-normal Carbon dioxide, Oxygen, and Mean arterial pressure After Cardiac Arrest and REsuscitation: Study protocol for a randomized pilot trial. Trials. 2017;18:507. doi: 10.1186/s13063-017-2257-0.
- Nolan J.P., Soar J., Cariou A., et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015. Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation. 2015;95:202–222. doi: 10.1016/j.resuscitation.2015.07.018.
- Rissin D.M., Fournier D.R., Piech T., et al. Simultaneous Detection of Single Molecules and Singulated Ensembles of Molecules Enables Immunoassays with Broad Dynamic Range. Anal Chem. 2011;83:2279–2285. doi: 10.1021/AC103161B.
- Cummins R.O., Chamberlain D.A., Abramson N.S., et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: The utstein style: A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, and Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation. 1991;84:960–975. doi: 10.1161/01.CIR.84.2.960.
- Neuhäuser M. In: International Encyclopedia of Statistical Science. Lovric M., editor. Springer; Berlin Heidelberg: 2011. Wilcoxon–Mann–Whitney Test; pp. 1656–1658.
- McHugh M.L. The Chi-square test of independence. Biochemia Medica. 2012;23:143–149. doi: 10.11613/BM.2013.018.
- Sahai H., Khurshid A. On analysis of epidemiological data involving a 2 × 2 contingency table: An overview of fisher’s exact test and yates’ correction for continuity. J Biopharm Stat. 1995;5:43–70. doi: 10.1080/10543409508835098.
- Duricki D.A., Soleman S., Moon L.D.F. Analysis of longitudinal data from animals with missing values using SPSS. Nat Protoc. 2016;11:1112–1129. doi: 10.1038/nprot.2016.048.
- Jawień W. Searching for an optimal AUC estimation method: a never-ending task? J Pharmacokinet Pharmacodyn. 2014;41:655–673. doi: 10.1007/s10928-014-9392-y.
- LaValley M.P. Logistic regression. Circulation. 2008;117:2395–2399. doi: 10.1161/CIRCULATIONAHA.106.682658.
- Youden W.J. Index for Index for rating diagnostic testsrating diagnostic tests. Cancer. 1950;3 doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>;2-3.
- Greiner M., Pfeiffer D., Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prevent Veterin Med. 2000;45:23–41. doi: 10.1016/S0167-5877(00)00115-X.
- Endisch C., Westhall E., Kenda M., et al. Hypoxic-Ischemic Encephalopathy Evaluated by Brain Autopsy and Neuroprognostication After Cardiac Arrest. JAMA Neurol. 2020;77:1430–1439. doi: 10.1001/JAMANEUROL.2020.2340.
- Busl K.M., Greer D.M. Hypoxic-ischemic brain injury: Pathophysiology, neuropathology and mechanisms. NeuroRehabilitation. 2010;26:5–13. doi: 10.3233/NRE-2010-0531.
- Järnum H., Knutsson L., Rundgren M., et al. Diffusion and perfusion MRI of the brain in comatose patients treated with mild hypothermia after cardiac arrest: A prospective observational study. Resuscitation. 2009;80:425–430. doi: 10.1016/J.RESUSCITATION.2009.01.004.
- Streitberger K.J., Endisch C., Ploner C.J., et al. Timing of brain computed tomography and accuracy of outcome prediction after cardiac arrest. Resuscitation. 2019;145:8–14. doi: 10.1016/J.RESUSCITATION.2019.09.025.
- Thelin E.P., Zeiler F.A., Ercole A., et al. Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: A systematic review. Front Neurol. 2017;8:300. doi: 10.3389/fneur.2017.00300.
- Luyt C.E., Galanaud D., Perlbarg V., et al. Diffusion tensor imaging to predict long-term outcome after cardiac arrest: A bicentric pilot study. Anesthesiology. 2012;117:1311–1321. doi: 10.1097/ALN.0b013e318275148c.
- Pluta R., Ułamek-Kozioł M., Januszewski S., Czuczwar S.J. Tau protein dysfunction after brain ischemia. J Alzheimer’s Dis. 2018;66:429–433. doi: 10.3233/JAD-180772.
- Rahaman P., del Bigio M.R. Histology of Brain Trauma and Hypoxia-Ischemia. Acad Foren Pathol. 2018;8:539. doi: 10.1177/1925362118797728.
- Helwig K., Seeger F., Hölschermann H., et al. Elevated Serum Glial Fibrillary Acidic Protein (GFAP) is Associated with Poor Functional Outcome After Cardiopulmonary Resuscitation. Neurocrit Care. 2017;27:68–74. doi: 10.1007/s12028-016-0371-6.
- Ebner F., Moseby-Knappe M., Mattsson-Carlgren N., et al. Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients. Resuscitation. 2020;154:61–68. doi: 10.1016/j.resuscitation.2020.05.016.
- Nielsen N., Wetterslev J., Cronberg T., et al. Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest. New Engl J Med. 2013;369:2197–2206. doi: 10.1056/NEJMOA1310519.
- Mörtberg E., Zetterberg H., Nordmark J., et al. Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia. Acta Anaesthesiol Scand. 2011;55:1132–1138. doi: 10.1111/j.1399-6576.2011.02505.x.
- Wihersaari L., Ashton N.J., Reinikainen M., et al. Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial. Intens Care Med. 2021;47:39–48. doi: 10.1007/s00134-020-06218-9.
- Moseby-Knappe M., Mattsson N., Nielsen N., et al. Serum Neurofilament Light Chain for Prognosis of Outcome after Cardiac Arrest. JAMA Neurol. 2019;76:64–71. doi: 10.1001/jamaneurol.2018.3223.
- Moseby-Knappe M., Mattsson-Carlgren N., Stammet P., et al. Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest. Intens Care Med. 2021;47:984–994. doi: 10.1007/S00134-021-06481-4.
- Ashton N.J., Suárez-Calvet M., Karikari T.K., et al. Effects of pre-analytical procedures on blood biomarkers for Alzheimer’s pathophysiology, glial activation, and neurodegeneration. Alzheimer’s Demen Diagn Assess Dis Monit. 2021;13 doi: 10.1002/DAD2.12168.
- Bazarian J.J., Biberthaler P., Welch R.D., et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17:782–789. doi: 10.1016/S1474-4422(18)30231-X.
- Chiu M.-J., Lue L.-F., Sabbagh M.N., Chen T.-F., Chen H.H., Yang S.-Y. Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays. Dement Geriatr Cogn Disord Extra. 2019;9:77–86. doi: 10.1159/000496099.
Source: PubMed